Background Precision medicine development is driven by the possibilities of next generation
sequencing, information technology and artificial intelligence and thus, raises a number of …

It is just over two decades since a small start-up firm called University Diagnostics launched
a mail-order genetic testing service in the UK in 1996. That same year, the US-based …

We bring together recent discussions on data capitalism and biocapitalization by studying
value flows in consumer genomics firms—an industry at the intersection between health …

Direct‐to‐consumer genetic tests (DTC‐GT) offer a variety of genetic health risk information.
Understanding evidence of impacts is required for effective policy to protect consumers and …

This study examines how the institutional context informs the ways in which healthy
recipients relate to genomic information. Through focus group data, it considers the trend of …

Genetic testing has become a vehicle through which basic constitutional relationships
between citizens and the state are revisited, reaffirmed, or rearticulated. The interplay …

While it has been argued that anonymity in gamete donation has been brought to an end by
legal changes and technological developments, Amelie Baumann suggests that this is in …

In January 2024, building on the Genomics Beyond Health report, the Department for
Education (DfE), with co-funding from the Government Office for Science (GO-Science) …

Direct-to-consumer (DTC) genetic tests (GT) enable consumers to access a wide range of
GT, without involving a healthcare professional, promoting an increasing disassociation of …

Personalised medicine involves new ways of classifying and stratifying people, in terms of
both existing conditions and behaviours, and especially predicted risk of future illness …